} Reuters Shares of CureVac, a German biotech company backed by Bill Gates, went as much as 18% into premarket trading on Thursday after the company said it was in talks with the European Commission to supply doses of its potential coronavirus vaccine. The potential contract with the European Commission …
Read More »
Reuters CureVac, a German-based biotechnology company, jumped $ 213.3 million and more than a third of its IPO price in its initial public offering on Friday. Shares of the company have continued to grow since its Friday IPO, gaining as much as 52% to $ 85 per share on Monday …
Read More »
AP Photo / Hans Pennink President Donald Trump announced Tuesday that the U.S. government has reached a deal with Moderna for 100 million doses of its coronavirus vaccine candidate. Shares of Moderna spiked as much as 10% on Wednesday. The company separately announced that the deal is worth $ 1.53 …
Read More »
Getty / Win McNamee JPMorgan CEO Jamie Dimon said in a Tuesday interview with MSNBC that “we are in a recession, but you will have a delayed effect to see the normal effect of recession.” The normal effects of the recession may not come until “late this year or early …
Read More »
In just over a week, Michigan’s risk of a coronavirus outbreak (COVID-19) has gone from a “high” risk level to a “medium” risk level by Covid Act Now. The Covid Act Now group of technologists, epidemiologists, health experts, and public policy leaders is identifying each state’s level of risk for …
Read More »